Strategic questions by Marvin Edeas, from Institut Cochin, INSERM U1016

During Targeting Microbiota 2016 World Congress which will be held from October 17 to 19, at Pasteur Institute, Paris, more than 100 communications (oral & poster) will be presented during three days.

With more than 400 attendees coming form academies and industries, we asked Marvin Edeas, from Institut Cochin, INSERM U1016, University Paris Descartes and as chairman of the scientific committee of Targeting Microbiota 2016 to comment about the strategic points and questions which will be discussed during Targeting Microbiota 2016.

In order to have a better picture of microbiota 2016 advances, we need to answer many questions:
- Can we modulate the quality and diversity of our microbiota?
- Where is the red line of the gut microbiota manipulation?

- What are the strategic mediators of gut microbiota?
- What is the perfect microbiota "signature" and how to use it as a biomarker to "predict" and/or treat many diseases?
- It is very easy today to analyze and study the microbiota, however it is very difficult to interpret the results. How the skills of bioinformaticians will lead us to a "golden standard"? 
- Can policy makers clarify the health claims and fecal microbiota transplantation regulation?

Marvin Edeas concluded: I wish that we have a strong discussion between all the actors to progress in our strategies to predict and treat many microbiota related diseases.

For more information about Targeting Microbiota 2016:





Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next